Terms: = Liver cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Treatment
120 results:
1. Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing.
Zheng L; Wang Y; Liu Z; Wang Z; Tao C; Wu A; Li H; Xiao T; Li Z; Rong W
Cancer Med; 2024 Apr; 13(7):e7043. PubMed ID: 38572921
[TBL] [Abstract] [Full Text] [Related]
2. FGF19 and its analog Aldafermin cooperate with MYC to induce aggressive hepatocarcinogenesis.
Ursic-Bedoya J; Desandré G; Chavey C; Marie P; Polizzi A; Rivière B; Guillou H; Assenat E; Hibner U; Gregoire D
EMBO Mol Med; 2024 Feb; 16(2):238-250. PubMed ID: 38228803
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic and predictive biomarkers in paediatric solid tumours.
Glembocki AI; Somers GR
Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
[TBL] [Abstract] [Full Text] [Related]
4. Comparative Clinicopathologic and Genomic Analysis of Hepatocellular Neoplasm, Not Otherwise Specified, and Hepatoblastoma.
Zhou S; Sarabia SF; Estrine D; Ostrow D; Schmidt RJ; Warren M; Raca G; Shillingford N; Wang L; Pawel B; Stein JE; Biegel JA; Lopez-Terrada D; Mascarenhas L; Ji J
Mod Pathol; 2024 Feb; 37(2):100385. PubMed ID: 37992967
[TBL] [Abstract] [Full Text] [Related]
5. Tumor biology, immune infiltration and liver function define seven hepatocellular carcinoma subtypes linked to distinct drivers, survival and drug response.
Wu R; Gao Y; Zhao X; Guo S; Zhou H; Zhang Y; Hou Y; Mei L; Zhi H; Wang P; Li X; Ning S; Zhang Y
Comput Biol Med; 2023 Dec; 167():107593. PubMed ID: 37883849
[TBL] [Abstract] [Full Text] [Related]
6. Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.
Cowzer D; White JB; Chou JF; Chen PJ; Kim TH; Khalil DN; El Dika IH; Columna K; Yaqubie A; Light JS; Shia J; Yarmohammadi H; Erinjeri JP; Wei AC; Jarnagin W; Do RKG; Solit DB; Capanu M; Shah RH; Berger MF; Abou-Alfa GK; Harding JJ
JCO Precis Oncol; 2023 Sep; 7():e2300272. PubMed ID: 37769223
[TBL] [Abstract] [Full Text] [Related]
7. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
[TBL] [Abstract] [Full Text] [Related]
8. Role of immune related genes in predicting prognosis and immune response in patients with hepatocellular carcinoma.
Chen Y; Shen C; Wu J; Yan X; Huang Q
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23519. PubMed ID: 37665680
[TBL] [Abstract] [Full Text] [Related]
9. Oncogenic β-catenin-driven liver cancer is susceptible to methotrexate-mediated disruption of nucleotide synthesis.
Liu F; Wu Y; Zhang B; Yang S; Shang K; Li J; Zhang P; Deng W; Chen L; Zheng L; Gai X; Zhang H
Chin Med J (Engl); 2024 Jan; 137(2):181-189. PubMed ID: 37612257
[TBL] [Abstract] [Full Text] [Related]
10. Association of Age With treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal cancer.
Meng L; Thapa R; Delgado MG; Gomez MF; Ji R; Knepper TC; Hubbard JM; Wang X; Permuth JB; Kim RD; Laber DA; Xie H
JAMA Netw Open; 2023 Jun; 6(6):e2320035. PubMed ID: 37358854
[TBL] [Abstract] [Full Text] [Related]
11. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes.
Chavda V; Zajac KK; Gunn JL; Balar P; Khadela A; Vaghela D; Soni S; Ashby CR; Tiwari AK
Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1821. PubMed ID: 37344125
[TBL] [Abstract] [Full Text] [Related]
12. An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma.
Wu X; Jin B; Liu X; Mao Y; Wan X; Du S
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10319-10333. PubMed ID: 37273105
[TBL] [Abstract] [Full Text] [Related]
13. Characterization of heterogeneous metabolism in hepatocellular carcinoma identifies new therapeutic target and treatment strategy.
Yang J; Zeng L; Chen R; Zheng S; Zhou Y; Chen R
Front Immunol; 2023; 14():1076587. PubMed ID: 37006288
[TBL] [Abstract] [Full Text] [Related]
14. Construction of a lipid metabolism-related risk model for hepatocellular carcinoma by single cell and machine learning analysis.
Mou L; Pu Z; Luo Y; Quan R; So Y; Jiang H
Front Immunol; 2023; 14():1036562. PubMed ID: 36936948
[TBL] [Abstract] [Full Text] [Related]
15. Can MRI features predict clinically relevant hepatocellular carcinoma genetic subtypes?
Liu X; Guo Y; Zhao L; Misdraji J; Kapur T; Abrams TA; Shyn PB
Abdom Radiol (NY); 2023 Jun; 48(6):1955-1964. PubMed ID: 36933025
[TBL] [Abstract] [Full Text] [Related]
16. Development of a TMErisk model based on immune infiltration in tumour microenvironment to predict prognosis of immune checkpoint inhibitor treatment in hepatocellular carcinoma.
Yan ZJ; Yu CT; Chen L; Wang HY
Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36882021
[TBL] [Abstract] [Full Text] [Related]
17. [Differential diagnostic between hepatocellular carcinoma and hepatoid carcinoma with bone metastasis revelation: What tools can be used?].
Neyrand S; Bringuier PP; Benzerdjeb N; Hervieu V; Fenouil T
Ann Pathol; 2023 Sep; 43(5):407-411. PubMed ID: 36822899
[TBL] [Abstract] [Full Text] [Related]
18. Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures.
Mokgautsi N; Kuo YC; Huang YJ; Chen CH; Mukhopadhyay D; Wu ATH; Huang HS
Cells; 2023 Jan; 12(2):. PubMed ID: 36672201
[TBL] [Abstract] [Full Text] [Related]
19. State of the art and perspectives in pediatric hepatocellular carcinoma.
Digiacomo G; Serra RP; Turrini E; Tiri A; Cavazzoni A; Alfieri R; Bertolini P
Biochem Pharmacol; 2023 Jan; 207():115373. PubMed ID: 36513143
[TBL] [Abstract] [Full Text] [Related]
20. Profound tumor response to combined CTLA-4 and PD-1 inhibition in systemic fourth line therapy observed in a patient with hepatocellular carcinoma harboring SETD2 and LRP1B mutations.
Reiter FP; Rau M; Kunzmann V; Kickuth R; Klein I; Neumann O; Stenzinger A; Schirmacher P; Geier A
Z Gastroenterol; 2023 Jan; 61(1):71-75. PubMed ID: 36379463
[TBL] [Abstract] [Full Text] [Related]
[Next]
